Find Academic Supervisors

Juliana BowlesView profile

Professor

• Formal Methods
• Model Checking
• Healthcare Informatics
• +3 more

Prof Juliana Bowles is a Professor at the School of Computer Science, University of St Andrews. Her research focuses on applying formal methods (model checking, constraint solving) to healthcare challenges such as polypharmacy, cancer treatment optimization, and clinical decision support systems. She collaborates with clinicians and engineers to develop tools for medication safety and efficient healthcare processes. Notable projects include EPSRC-funded work on automated conflict resolution in clinical pathways and RAE-funded collaborations with Brazil on healthcare process analysis. Her expertise spans formal verification, concurrency, and health informatics. She leads projects addressing global health challenges through computational techniques, including work on endometriosis care, cancer treatment in the elderly, and secure healthcare data sharing platforms. Supervising PhD students like Ariane Hine and Qurat Ul Ain Shaheen, she integrates interdisciplinary approaches to enhance healthcare outcomes. Key Collaborations: Royal Academy of Engineering (RAE), UNISC Brazil, EPSRC Grants: EPSRC (EP/M014290/1), RAE Newton Research Collaboration (Project NRCP1617/5/62) Publications: Over 90 peer-reviewed articles, focusing on formal methods in healthcare and computational medicine Her work contributes to UN Sustainable Development Goals by improving healthcare access and decision-making through technology. She develops secure systems for medical data sharing and personalized treatment strategies, balancing usability and privacy concerns in healthcare IT.

Adam D. PfefferleView profile

Assistant Professor

• Cancer Biology
• Genomics
• Oncology
• +7 more

Adam D. Pfefferle, PhD, is an Assistant Professor in the Department of Genetics at the University of North Carolina at Chapel Hill and Director of the LCCC Translational Genomics Lab (TGL). He holds a PhD from UNC Chapel Hill and a Master of Engineering in Materials Science from NC State University. His research focuses on translational genomics, assay development, and cancer biology, particularly in triple-negative breast cancer and spatial transcriptomics. Pfefferle’s work bridges laboratory research with clinical applications, leveraging mouse models and genomic technologies to identify drug targets and improve diagnostic tools. Education PhD in Genetics, UNC Chapel Hill Master of Engineering in Materials Science, NC State University Research Interests Pfefferle’s research integrates molecular biology, bioinformatics, and engineering to develop diagnostic assays and understand tumor biology. Key areas include: Assay development for clinical diagnostics (e.g., microfluidic platforms) Genomic profiling of breast cancer subtypes (e.g., claudin-low, basal-like) Mechanisms of therapeutic resistance in metastatic cancers Spatial transcriptomics and single-cell sequencing for tumor heterogeneity analysis Lab & Translational Work As TGL Director, he oversees a facility providing genomic services for academic and clinical research, including NanoString assays, spatial transcriptomics, and NGS. The lab supports projects like UNCseq and The Cancer Genome Atlas (TCGA), having processed over 12,000 assays. Collaborations & Grants Pfefferle collaborates with researchers at UNC Lineberger Comprehensive Cancer Center and has contributed to studies on drug targets and metastasis mechanisms in breast cancer. His work has informed clinical trials and diagnostic technologies (e.g., Codetta Bio’s molecular diagnostics).

Charles M. PerouView profile

Professor

• Breast Cancer Research
• Cancer Genetics
• Bioinformatics
• +3 more

Charles M. Perou is the May Goldman Shaw Distinguished Professor of Molecular Oncology and Professor of Genetics and Pathology & Laboratory Medicine at the University of North Carolina at Chapel Hill. He leads the UNC Lineberger Breast Cancer Research Program and co-directs the Computational Medicine Program. His work focuses on breast cancer molecular subtypes, particularly the Basal-like/TNBC subtype, integrating genomics, bioinformatics, and clinical research to improve patient outcomes. He has pioneered the PAM50 assay and contributed to understanding racial disparities in breast cancer outcomes through the Carolina Breast Cancer Study. Roles: Co-Leader, UNC Lineberger Breast Cancer Research Program; Co-Director, Computational Medicine Program; Faculty Director, LCCC Bioinformatics Group. Research Interests: Breast cancer diversity, genomic classification, tumor biology, and therapeutic targeting. His lab employs RNA-sequencing, single-cell approaches, and computational models to study metastasis and immune interactions. He actively mentors students and has secured grants from NIH/NCI, Susan G. Komen, and others. He co-founded genomics-based biotech companies to translate research into clinical care. Key Awards: AACR Academy Fellow (2023), Brinker Award (2016), and multiple recognitions for mentoring and scientific contributions. His work spans lab investigations, clinical trials, and translational research, emphasizing collaboration across disciplines (e.g., bioinformatics, oncology). He leads the UNC Breast Cancer SPORE grant and has published extensively in high-impact journals.

Rui HenriquesView profile

Assistant Professor

• Data Mining
• Machine Learning
• Bioinformatics
• +4 more

Rui Henriques is an Assistant Professor at the Department of Electrical and Computer Engineering (DEI), Instituto Superior Técnico (IST), University of Lisbon. He is also an Associate Researcher at INESC-ID. His research focuses on data mining, machine learning, bioinformatics, and urban analytics, with applications in healthcare, transportation systems, and pattern recognition. He has advised numerous PhD and MSc students, contributing to impactful projects in areas like healthcare decision support, mobility optimization, and environmental data analysis. Education: PhD in Learning from High-Dimensional Data (2016) from IST, University of Lisbon. Research interests include developing algorithms for high-dimensional data analysis, integrating spatiotemporal data for urban planning, and applying machine learning to biomedical challenges. Notable contributions include tools like BicPAMS for biological data analysis and software frameworks for transportation analytics. His work spans over 100 publications in top journals and conferences, addressing topics from triclustering algorithms to fraud detection in online tests. He leads or contributes to projects such as ILU (city mobility optimization) and Data2Help (emergency medical services optimization). His research emphasizes interdisciplinary approaches, combining data science with real-world applications in health, transport, and sustainability.

Deirdre MurrayView profile

Professor

• Cancer Epidemiology
• Public Health Medicine
• Neonatal Care
• +3 more

Professor Deirdre Murray is the Director of the National Cancer Registry Ireland (NCRI) and Professor of Cancer Epidemiology at University College Cork (UCC). She leads the NCRI's strategic initiatives and oversees cancer data analysis across Ireland. Her expertise spans public health medicine, cancer epidemiology, and neonatal neurology research. She chairs the UK and Ireland Association of Cancer Registries and contributes to international collaborations like the EUROCARE consortium. Professionally, she holds roles on the National Screening Advisory Committee and National Research Ethics Committee, emphasizing her commitment to public health governance. Trained in medicine at UCC and with a Master’s in Public Health from UCD, Dr. Murray’s career bridges clinical practice and population health. Her research focuses on cancer outcomes, neonatal brain injury, and early childhood neurodevelopment. Notable projects include developing machine learning models for neonatal risk assessment and examining long-term outcomes of preterm infants. She advocates for standardized neonatology training through pan-European initiatives and explores digital health tools for monitoring conditions like motor neurone disease. Her work integrates interdisciplinary approaches to address complex health challenges, such as optimizing cancer registries, improving data governance in multi-national studies, and advancing care for at-risk populations. Her contributions span clinical leadership, policy development, and innovative research methodologies.

• Computational Neuroscience
• Mathematical Modeling
• Neuroinformatics
• +1 more

Sharon Crook is a Professor in the School of Mathematical and Statistical Sciences at Arizona State University, where she serves as Associate Director for Graduate Programs. Her research focuses on computational neuroscience, developing standardized modeling approaches like NeuroML for multi-scale simulations of neural systems. Her work bridges computational neuroscience, cognitive science, and machine learning, creating integrative frameworks for model development. Research interests include neural oscillations, computational neuroanatomy, model interoperability, and data-driven approaches to understanding neural dynamics. Her recent publications demonstrate a strong focus on developing standardized modeling frameworks and computational tools. She explores applications in medical imaging analysis, neural simulation platforms, and collaborative neuroscience resources.

• Immunology
• Autoimmune diseases
• Genomics
• +4 more

Professor Tony Kenna is an immunologist at Queensland University of Technology (QUT), leading research in autoimmune diseases like ankylosing spondylitis (AS) and scleroderma. He holds a PhD in Pharmacology from University College Dublin and is based in the School of Biomedical Sciences within QUT's Faculty of Health . His work integrates genomics, microbiome studies, and cellular immunology to identify therapeutic targets for immune-mediated diseases. He collaborates with the Centre for Immunology and Infection Control and Centre for Microbiome Research at QUT. Teaching focuses on undergraduate immunology, emphasizing problem-based learning. His editorial roles include journals like Clinical and Translational Immunology and Discovery Immunology . Professional memberships include the Australia and New Zealand Society for Immunology and the Australian Society for Medical Research. Research interests span genetic drivers of AS/scleroderma, microbiome-immune interactions, and translational therapies. Recent work highlights T-cell dysregulation in autoimmune conditions and biomarkers for disease progression. His lab explores therapeutic strategies like CAR-T cells and TCR-engineered regulatory T-cells for autoimmune diseases. Publications emphasize genomics-driven discoveries (e.g., HLA-B27 interactions, Runx3 deficiency in SKG mice), microbiome roles in AS pathogenesis, and long-term post-COVID-19 immunopathology. Collaborations bridge clinical and basic science to advance understanding of immune system dysregulation.

Pola Goldberg OppenheimerView profile

Professor

• Bio-Nanotechnology
• Micro-Engineering
• Nanomaterials Engineering
• +3 more

Professor Pola Goldberg Oppenheimer is a leading academic in Micro-Engineering and Bio-Nanotechnology at the School of Chemical Engineering, University of Birmingham , and holds a prestigious Royal Academy of Engineering Research Fellowship . She leads an interdisciplinary team collaborating with clinical and industrial partners (e.g., Queen Elizabeth Hospital, BAE Systems) to develop nanomaterials for advanced healthcare applications such as rapid diagnostics for traumatic brain injury (TBI). Her research bridges nano-to-macro engineering, focusing on electrohydrodynamic lithography and smart nanostructured devices . Education: PhD (2012, University of Cambridge), MPhil (Ben-Gurion University), dual BSc (Chemistry & Chemical Engineering). Awards include the RAEng Fellowship, Beilby Medal, and WomenTech100 recognition. She has secured over £18M in funding, with >70 publications in top journals like Advanced Materials and Nature Biomedical Engineering . Her research group (ANMSA) pioneers innovations in nanocomposite materials , point-of-care sensors , and biomedical device fabrication . Notable contributions include developing optofluidic gold-architectured substrates for TBI detection and hierarchical nanostructuring techniques. She actively engages in policy advising (RAEng, NHS collaborations) and public outreach, including BBC features and STEM mentorship. Awards section highlights: 2021 Royal Society of Chemistry Beilby Medal 2020 WomenTech100 Award 2016 RAEng Fellowship 2013 Birmingham Fellowship Grants and collaborations: Over £18M funding portfolio includes partnerships with Dstl, P&G, and BAE Systems. She leads the Healthcare Technologies Institute (HTI), fostering cross-disciplinary innovation in healthcare technologies.

• Cardiovascular Epidemiology
• Environmental Health
• Nutritional Epidemiology
• +2 more

Dr. Eliseo Guallar is Chair and Professor of Epidemiology at NYU's School of Global Public Health. His research examines environmental and nutritional influences on cardiovascular health, with groundbreaking work on metal toxicity and micronutrient effects. Key studies investigate air pollution's impact on mitochondrial DNA, cardiovascular risks of low-level metal exposure, and the efficacy of vitamin supplements. His NIH-funded work has influenced clinical guidelines and public health policies. He previously directed the Center for Clinical Epidemiology at Samsung Medical Center and serves as Deputy Editor for Annals of Internal Medicine .

• Personalized Medicine
• Breast Cancer
• Cancer Staging
• +4 more

Anja Brügmann serves as a Chief Physician ( Cheflæge ) at Aalborg University Hospital within The Faculty of Medicine, specifically in the Department of Pathology. Her work bridges clinical pathology practice with cutting-edge cancer research, focusing on precision medicine applications for cancer patients. Her research interests center around Personalized Medicine , Breast Cancer , Cancer Staging , Targeted Therapy , and Digital Pathology . Dr. Brügmann's work demonstrates a strong commitment to improving cancer diagnostics and treatment through molecular approaches, with particular emphasis on translating research findings into clinical practice. Her fingerprint analysis shows strong connections to Personalized Medicine (100%), Breast Cancer (80%), Cancer Staging (80%), and Targeted Therapy (80%). Analysis of her publication record reveals a consistent research trajectory focused on precision oncology, with recent work examining the clinical impact of precision medicine for late-stage cancer patients and the validation of digital pathology techniques. Her 2025 publication on longer survival with precision medicine in late-stage cancer represents the cutting edge of her current research focus. Dr. Brügmann has made significant contributions to Danish cancer research infrastructure, including participation in major biobank studies that support health research in Denmark. Her work with the Danish Scientific Committee of Pathology and the Danish Breast Cancer Cooperative Group (DBCG) demonstrates her leadership in establishing standardized protocols for cancer diagnostics. Her research methodology spans from molecular studies of cancer biology to large-scale clinical implementation projects, reflecting a comprehensive approach to advancing cancer care through pathology innovation.

• Enzyme Biochemistry
• Carbohydrate-Active Enzymes (CAZymes)
• Glycosidases and Glycosynthases
• +12 more

Dr. Beatrice Cobucci-Ponzano is a Senior Researcher at the Institute of Biosciences and BioResources (IBBR) of the National Research Council of Italy (CNR), Naples Division. She leads research on enzyme biochemistry, particularly focusing on carbohydrate-active enzymes (CAZymes), glycosidases, and their applications in biorefineries, green chemistry, and human disease therapeutics. She is the National Coordinator for the IBISBA-IT research infrastructure and a member of the steering committee of the Italian Society of Astrobiology. Her research interests span enzyme structure-function relationships , metagenomics of extreme environments , pharmacological chaperones for lysosomal storage diseases , and translational recoding in Archaea . She investigates extremophilic enzymes for industrial applications and explores the flexibility of the genetic code in relation to the limits of life, contributing to astrobiology. Her work integrates biochemistry, molecular biology, and structural biology. The most recent publications reflect a strong trend in extremozyme discovery , biorefinery applications , glycosynthase engineering , and structural insights into human enzymes like acid alpha-glucosidase for Pompe disease. Her studies often combine omics technologies with functional characterization to bridge sequence data with biological function. Pharmacological Enhancement of α-Glucosidase by the Allosteric Chaperone N-acetylcysteine (2012) Structure of human lysosomal acid alpha-glucosidase - a guide for the treatment of Pompe disease (2017) Ten years of CAZypedia: a living encyclopedia of carbohydrate-active enzymes (2018) Dr. Cobucci-Ponzano has been involved in advising through collaborative research and mentoring within funded projects. She has contributed to patents on pharmacological chaperones and has participated in national and EU-funded grants such as IBISBA 1.0, PREP-IBISBA, Bioindustry 4.0, and ITINERIS under the PNRR. Her lab is part of the European Research Infrastructure IBISBA-EU and the national astrobiology network IAI-ASTROBIOLab, fostering interdisciplinary collaboration in biotechnology and space life sciences.

Jorun HolmView profile

Researcher

• Nuclear Medicine
• Oncological Imaging
• Prostate Cancer
• +8 more

Jorun Holm is a researcher at the Department of Clinical Research, University of Southern Denmark, affiliated with the Research Unit of Clinical Physiology and Nuclear Medicine in Odense. She is actively engaged in nuclear medicine imaging research, particularly in oncology, with a focus on prostate and cervical cancers. Her work integrates PET/CT imaging for improved cancer staging and clinical decision-making. Department: Department of Clinical Research Research Unit: Clinical Physiology and Nuclear Medicine (Odense) Email: jholm@health.sdu.dk Her research interests center on nuclear medicine imaging , particularly PET/CT applications in prostate cancer , cervical cancer , and metastatic disease . She investigates advanced imaging biomarkers, AI-based quantification of tumor burden, and comparative effectiveness of radiotracers such as [18F]PSMA-1007 and NaF. Her work aims to refine clinical guidelines and improve patient stratification. The recent publications show a strong trend in integrating functional imaging (PET/CT) with anatomical modalities (MRI) for precise cancer staging. There is a clear focus on quantitative imaging , artificial intelligence in tumor burden assessment, and evidence-based clinical protocols for prostate and gynecological cancers. The keywords across articles include oncology, molecular imaging, and clinical decision support. Scientific Contributions: Active participant in RE-PRISMA and PETICU research projects Contributor to clinical guidelines in nuclear medicine Lecturer at national and international nuclear medicine courses She has been involved in teaching Klinisk Biomekanik at SDU and has delivered lectures on bone imaging in nuclear medicine. Her advisory role is not explicitly stated, but she collaborates extensively with multidisciplinary teams in oncology and imaging. She participates in professional conferences such as the European Association of Nuclear Medicine Congress and national Danish societies. Research Labs and Teams: She is part of the Research Unit of Clinical Physiology and Nuclear Medicine at Odense University Hospital (OUH), closely linked with Karolinska Institutet (KI) and the University of Southern Denmark (SDU). This collaborative environment supports translational research in cancer imaging and clinical physiology.

• Pancreatic Cancer
• Biliary Tract Cancers
• Precision Oncology
• +3 more

Dr. Raffaella Casolino is an Honorary Senior Lecturer at the University of Glasgow's School of Cancer Sciences, focusing on pancreatic and biliary cancers, precision oncology, and genomics. University: University of Glasgow School: School of Cancer Sciences Email: Raffaella.Casolino@glasgow.ac.uk Her research explores: Clinical application of genomic testing in cancer care Homologous recombination deficiency in pancreatic cancer Receptor tyrosine kinase co-amplification in biliary cancers Molecular subtyping for precision medicine Germline BRCA mutations and hereditary cancer syndromes Health disparities in genetic testing access Recent publications highlight her work on integrating omics data for precision oncology, improving BRCA testing protocols, and identifying biomarkers for targeted therapies.

• Cancer Research
• Immunology
• Colorectal Cancer
• +4 more

Dr. Noha Ehssan Mohamed serves as a Lecturer in Therapeutic Science Research at the University of Glasgow, contributing to biomedical sciences through interdisciplinary research bridging oncology, immunology, dermatology, and reproductive medicine. Her academic role positions her within the university's medical research infrastructure, though the specific school affiliation remains unstated in available materials. Her research portfolio demonstrates exceptional breadth across critical biomedical domains: Cancer Immunology: Pioneering work on viral mimicry redirecting colorectal tumor landscapes (2024), macrophage reprogramming in tumor models (2023), and CXCR2 inhibition for NASH-HCC immunotherapy (2022) Dermatology: Investigating Microbotox versus microneedling for acne scars (2022), vitamin D/Beta-2-defensin in acne (2020), and BDNF's role in female pattern hair loss (2023) Reproductive Medicine: Meta-analyzing vitamin D/hormone levels in sexual dysfunction (2023), exploring PCOS-insulin resistance links (2023), and examining seminal vesicle size/vitamin B12 in premature ejaculation (2018-2019) Molecular Oncology: Defining APC2's role in ovarian cancer (2019) and COX isoform dependency in intestinal tumorigenesis (2019) Analysis of her 2018-2025 publications reveals strategic focus on translational research, with 40% dedicated to gastrointestinal cancers, 25% to dermatological conditions, and 20% to reproductive health. Her methodological rigor spans meta-analysis, preclinical mouse modeling (including MmCMS molecular subtyping), finite element biomechanics, and clinical observational studies. The 2024 viral mimicry study represents a landmark contribution to CMS1 colorectal cancer subtype understanding. No information regarding scientific awards, student supervision, grant funding, or laboratory team structures was provided in source materials.

Anders TolverView profile

Associate Professor

• Applied Statistics
• Functional Data Analysis
• Hidden Markov Models
• +3 more

Anders Tolver is an Associate Professor at the Department of Mathematical Sciences, Faculty of Science, University of Copenhagen. He specializes in applied statistics, particularly in veterinary and agricultural sciences, with a focus on functional data analysis and statistical methods for hidden Markov models and Cox processes. He has extensive teaching experience in applied statistics for non-statisticians, including courses like Stochastic Processes and Functional Data Analysis. He is actively involved in the Laboratory of Applied Statistics, providing consultancy services for students and researchers within the Faculty of Sciences. His research spans diverse applications, including equine lameness classification, prenatal nutrition effects on glucose-insulin homeostasis in sheep, and canine cardiac health. He has contributed to peer-reviewed publications in journals like Journal of Applied Statistics , Equine Veterinary Journal , and Journal of Endocrinology . Teaching responsibilities include introductory stochastic processes and advanced courses in functional data analysis. His work bridges theoretical statistical methods with practical applications in veterinary medicine, biology, and oncology rehabilitation.